pd168393 and marimastat

pd168393 has been researched along with marimastat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cartee, TV; Pollack, BP; Sapkota, B	1

Other Studies

1 other study(ies) available for pd168393 and marimastat

Article	Year
Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jul-01, Volume: 17, Issue:13 Topics: Antibodies, Blocking; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line; Cell Line, Tumor; Cetuximab; ErbB Receptors; Gene Expression Regulation; HCT116 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Hydroxamic Acids; Immunologic Factors; Interferon-gamma; Keratinocytes; Models, Biological; Nuclear Proteins; Protein Kinase Inhibitors; Quinazolines; Skin; Trans-Activators	2011

Article

Year

Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jul-01, Volume: 17, Issue:13

Topics: Antibodies, Blocking; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line; Cell Line, Tumor; Cetuximab; ErbB Receptors; Gene Expression Regulation; HCT116 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Hydroxamic Acids; Immunologic Factors; Interferon-gamma; Keratinocytes; Models, Biological; Nuclear Proteins; Protein Kinase Inhibitors; Quinazolines; Skin; Trans-Activators

2011